[PDF] jbuon.com

[PDF][PDF] Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer

AA Tentes, N Pallas, C Karamveri, D Kyziridis… - jbuon.com
Purpose: Peritoneal carcinomatosis of pancreatic cancer is generally considered for
palliative treatment. The purpose of this study was to report the outcome of cytoreductive …
被引用次数：49 相关文章

Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer.

AA Tentes, N Pallas, C Karamveri… - Journal of BU ON …, 2018 - europepmc.org
PURPOSE: Peritoneal carcinomatosis of pancreatic cancer is generally considered for
palliative treatment. The purpose of this study was to report the outcome of cytoreductive …
[PDF] jbuon.com

[PDF][PDF] Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer

AA Tentes, N Pallas, C Karamveri, D Kyziridis… - jbuon.com
Purpose: Peritoneal carcinomatosis of pancreatic cancer is generally considered for
palliative treatment. The purpose of this study was to report the outcome of cytoreductive …

[引用][C] Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer

AA Tentes - J BUON, 2018 - cir.nii.ac.jp
Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …

Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer

AA Tentes, N Pallas, C Karamveri… - Journal of BU ON …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose Peritoneal carcinomatosis of pancreatic cancer is generally considered for
palliative treatment. The purpose of this study was to report the outcome of cytoreductive …